Publicacións en colaboración con investigadores/as de Hospital POVISA (4)

2023

  1. Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 141-155

2021

  1. Efficacy of mepolizumab in usual clinical practice and characteristics of responders: Mepolizumab in usual clinical practice

    Respiratory Medicine, Vol. 187

2018

  1. Assessing adherence to inhaled medication in asthma: Impact of once-daily versus twice-daily dosing frequency. The ATAUD study

    Journal of Asthma, Vol. 55, Núm. 9, pp. 933-938

2016

  1. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152